A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Devaux, Yvan ^a   Vausort, Melanie ^a   McCann, Gerry P ^b   Kelly, Dominic ^b   Collignon, Olivier ^a   Ng, Leong L ^b   Wagner, Daniel R ^a,c   Squire, Iain B ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c Centre Hospitalier   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; MICRORNA; MICRORNA 101; MICRORNA 150; MICRORNA 16; MICRORNA 27A; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WALL MOTION INDEX SCORE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HEART VENTRICLES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PHENOTYPE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84881530141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070644     Document Type: Article

References (30)

1. Torabi A, Cleland JG, Khan NK, Loh PH, Clark AL, et al. (2008) The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J 29: 859-870.
2. Talwar S, Squire IB, Downie PF, McCullough AM, Campton MC, et al. (2000) Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 21: 1514-1521.
3. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
5. Creemers EE, Tijsen AJ, Pinto YM, (2012) Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? Circ Res 110: 483-495.
6. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3: 499-506.
7. Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, et al. (2012) Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction. Clin Chem 58: 559-567.
8. Zile MR, Mehurg SM, Arroyo JE, Stroud RE, Desantis SM, et al. (2011) Relationship Between The Temporal Profile of Plasma microRNA and Left Ventricular Remodeling In Patients Following Myocardial Infarction. Circ Cardiovasc Genet 4: 614-619.
9. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, et al. (2011) Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 51: 872-875.
10. Devaux Y, Vausort M, McCann G, Zangrando J, Kelly D, et al. (2013) MicroRNA-150: A Novel Marker of Left Ventricular Remodeling After Acute Myocardial Infarction. Circ Cardiovasc Genet April 1. DOI/circgenetics.
11. Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, et al. (2007) Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28: 711-718.
12. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, et al. (2002) N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106: 2913-2918.
13. Tobin J, (1958) Estimation of relationships for limited dependent variables. Econometrica 26: 24-36.
14. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172 discussion 207-112.
15. Steyerberg EW, Harrell FE Jr, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, et al. (2001) Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774-781.
16. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, et al. (2012) Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction. J Am Coll Cardiol 60: 290-299.
17. Zhu H, Fan GC, (2012) Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res 94: 284-292.
18. Goretti E, Rolland-Turner M, Léonard F, Zhang L, Wagner DR, et al. (2013) MicroRNA-16 affects key functions of human endothelial progenitor cells. J Leukoc Biol In press.
19. Abdellatif M, (2012) Differential Expression of MicroRNAs in Different Disease States. Circ Res 110: 638-650.
20. Da Costa Martins PA, De Windt LJ, (2012) MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 93: 563-572.
21. Yamamoto K, Ohki R, Lee RT, Ikeda U, Shimada K, (2001) Peroxisome Proliferator-Activated Receptor γ Activators Inhibit Cardiac Hypertrophy in Cardiac Myocytes. Circulation 104: 1670-1675.
22. Belevych AE, Sansom SE, Terentyeva R, Ho HT, Nishijima Y, et al. (2011) MicroRNA-1 and-133 Increase Arrhythmogenesis in Heart Failure by Dissociating Phosphatase Activity from RyR2 Complex. PLoS ONE 6: e28324.
23. Yang B, Lin H, Xiao J, Lu Y, Luo X, et al. (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491.
24. Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E, et al. (2012) MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death. The Journal of Clinical Investigation 122: 1222-1232.
25. Nishi H, Ono K, Horie T, Nagao K, Kinoshita M, et al. (2011) MicroRNA-27a Regulates Beta Cardiac Myosin Heavy Chain Gene Expression by Targeting Thyroid Hormone Receptor β1 in Neonatal Rat Ventricular Myocytes. Molecular and Cellular Biology 31: 744-755.
26. Pan Z, Sun X, Shan H, Wang N, Wang J, et al. (2012) miR-101 Inhibited Post-Infarct Cardiac Fibrosis and Improved Left Ventricular Compliance via FOS/TGFβ1 Pathway. Circulation July 18.
27. Sadegh MK, Ekman M, Rippe C, Uvelius B, Swärd K, et al. (2012) Deletion of Dicer in Smooth Muscle Affects Voiding Pattern and Reduces Detrusor Contractility and Neuroeffector Transmission. PLoS ONE 7: e35882.
28. Senn S, Julious S, (2009) Measurement in clinical trials: a neglected issue for statisticians? Stat Med 28: 3189-3209.
29. Fedorov V, Mannino F, Zhang R, (2009) Consequences of dichotomization. Pharm Stat 8: 50-61.
30. Mann DL, Barger PM, Burkhoff D, (2012) Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target? J Am Coll Cardiol 60: 2465-2472.